犬アトピー性皮膚炎市場：製品、アレルゲン、投与経路、流通チャネル、エンドユーザー別-2025-2030年世界予測

犬アトピー性皮膚炎市場は、2023年に15億7,000万米ドルと評価され、2024年には16億9,000万米ドルに達すると予測され、CAGR 8.40％で成長し、2030年には27億6,000万米ドルに達すると予測されています。

犬アトピー性皮膚炎（CAD）は、アレルゲンによる皮膚の炎症を特徴とする、犬に蔓延するアレルギー疾患です。効果的なCAD治療の必要性は、ペット飼育の増加とペットの健康に対する意識の高まりによって強調され、革新的な治療への需要を後押ししています。CAD治療の用途は、専門的な皮膚科サービスを提供する動物病院から、抗ヒスタミン剤や免疫抑制剤を配合したホームケア製品まで多岐にわたる。最終用途の範囲には主に、ペットの福祉を向上させ症状を緩和するために強化された治療オプションを求めるペットの飼い主や獣医専門家が含まれます。市場の成長は、バイオテクノロジーや医薬品の進歩、研究開発投資の増加、より効果的で副作用の少ない標的療法を提供する新製品の発売によって大きく牽引されています。さらに、ペットアレルギーの有病率の上昇や、飼い主がペットを家族の一員として扱うようになったというペットの人間化が、高価格の治療ソリューションの機会を生み出しています。しかし、規制当局の厳しい承認、長期投薬による副作用の可能性、革新的治療法の高コストといった制約が課題となっています。さらに、治療に対するペットの反応にばらつきがあること、CADの遺伝的・環境的誘因をより深く理解する必要があることなどもハードルとなっています。市場開拓の主な可能性は、新規生物製剤の開発、個々のペットのニーズに合わせた治療を行う個別化医療アプローチ、CADの早期かつ正確な同定を可能にする画期的な診断ツールなどです。イノベーション分野は、データ分析とAI駆動型プラットフォームを統合してアレルギーパターンを予測し、予防措置をカスタマイズすることに重点を置いています。市場はダイナミックで、非侵襲的治療、栄養補助食品、プロバイオティクス・ソリューションへのシフトが進んでおり、各社が満たされていない消費者ニーズに対応し、CADに対する治療手段を拡大しようと努力していることから、将来性が豊かであることが示唆されます。有効性と手頃な価格のバランスをとることは、競合情勢の中で成長を獲得し、幅広い普及を目指す企業にとって極めて重要です。

市場力学：急速に進化する犬アトピー性皮膚炎市場の主要市場インサイトを公開

犬アトピー性皮膚炎市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • ペット飼育数の増加と犬のアレルゲンに関する汚染の増加
  • 天然成分または非薬理学的方法への注目の高まり
• 市場抑制要因
  • ペットへの適応外薬物使用の増加
• 市場機会
  • 犬アトピー性皮膚炎（CAD）の研究開発投資による製品上市の増加
  • ペット保険への継続的な需要と飼い主の関心の高まり
• 市場の課題
  • CADの複雑な病因と治療効果と安全性への懸念

ポーターのファイブフォース：犬アトピー性皮膚炎市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：犬アトピー性皮膚炎市場における外部からの影響の把握

外部マクロ環境要因は、犬アトピー性皮膚炎市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析犬アトピー性皮膚炎市場における競合情勢の把握

犬アトピー性皮膚炎市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス犬アトピー性皮膚炎市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、犬アトピー性皮膚炎市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨犬アトピー性皮膚炎市場における成功への道筋を描く

犬アトピー性皮膚炎市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • ペット飼育数の増加と犬のアレルゲンに関連する汚染の増加
    • 天然成分や非薬理学的方法への注目が高まる
  • 抑制要因
    • ペットにおける適応外医薬品の使用増加
  • 機会
    • 犬アトピー性皮膚炎（CAD）のR&D投資製品発売の増加
    • ペット保険の継続的な需要とペット所有者の懸念の高まり
  • 課題
    • CADの複雑な病因と治療の有効性と安全性に関する懸念
• 市場セグメンテーション分析
  • 製品：CADの効果的な治療のための抗ヒスタミン薬とグルココルチコイドの使用拡大
  • アレルゲン：ダニや微小な寄生虫がCADの主な原因である
  • 投与経路：注射剤と経口剤が最も好ましい投与方法です。
  • 流通チャネル：オンライン流通チャネルを通じたCAD医薬品の入手可能性の向上
  • エンドユーザー：診療所におけるCAD診断の増加と効果的な治療の必要性
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 犬アトピー性皮膚炎市場：製品別

• 抗ヒスタミン薬
• グルココルチコイド
• 免疫抑制剤
• モノクローナル抗体

第7章 犬アトピー性皮膚炎市場アレルゲン

• ふけ
• 微生物
• ダニ
• 花粉

第8章 犬アトピー性皮膚炎市場：投与経路別

• 注射可能
• オーラル
• 話題

第9章 犬アトピー性皮膚炎市場：流通チャネル別

• 病院・クリニック
• オンライン
• 小売獣医

第10章 犬アトピー性皮膚炎市場：エンドユーザー別

• 病院
• 獣医クリニック

第11章 南北アメリカの犬アトピー性皮膚炎市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の犬アトピー性皮膚炎市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの犬アトピー性皮膚炎市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • ゾエティス、米国ネブラスカ州リンカーンに最新鋭の施設を開設
  • ゾエティス社、アレルギー性皮膚炎に伴う掻痒の抑制および犬のアトピー性皮膚炎の抑制を目的としたアポクエルチュアブル（オクラシチニブチュアブル錠）のFDA承認を発表
  • ILCセラピューティクスはデクラ・ファーマシューティカルズと戦略的研究開発提携を締結
  • ビオイベリカ、脂質ベースのバイオスフェーン成分を使用したアトピー性皮膚炎用の犬・猫用首輪を発売
  • ロイヤルカナン北米、犬アトピー性皮膚炎の管理に役立つSKINTOPICの発売を発表
• 戦略分析と提言

企業一覧

• AB Science SA
• AbbVie, Inc.
• Agrolabo SpA
• Bimeda, Inc.
• Bioceltix JSC
• Bioiberica S.A.U.
• Boehringer Ingelheim International GmbH
• Ceva Sante Animale
• Dechra Pharmaceuticals PLC
• Deep Marine Collagen
• Elanco Animal Health Incorporated
• Farnam Companies, Inc.
• IDEXX Laboratories, Inc.
• Incyte Corporation
• Kemin Industries, Inc.
• LEO Pharma A/S
• Merck & Co. Inc.
• Natural Dog Company
• Nextmune
• Nippon Zenyaku Kogyo Co., Ltd.
• Novartis AG
• Ourofino Animal Health
• Pfizer Inc
• Phibro Animal Health Corporation
• Regeneron Pharmaceuticals, Inc
• Saiba Animal Health AG
• Toray Industries Inc.
• Vetoquinol S.A.
• Virbac Corporation
• Zinpro Corporation
• Zoetis Inc.
• Zymox by Pet King Brands LLC

LIST OF FIGURES

• FIGURE 1. CANINE ATOPIC DERMATITIS MARKET RESEARCH PROCESS
• FIGURE 2. CANINE ATOPIC DERMATITIS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. CANINE ATOPIC DERMATITIS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. CANINE ATOPIC DERMATITIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CANINE ATOPIC DERMATITIS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CANINE ATOPIC DERMATITIS MARKET DYNAMICS
• TABLE 7. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DANDER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY MICROORGANISMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY MITES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY POLLEN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY RETAIL VETERINARY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY VETERNARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 46. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 47. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 48. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 73. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 74. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 75. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 78. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 79. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 80. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 162. ITALY CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 163. ITALY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 164. ITALY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 165. ITALY CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 166. ITALY CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 182. POLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 183. POLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 184. POLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 185. POLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 186. POLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 187. QATAR CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 188. QATAR CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 189. QATAR CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 190. QATAR CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 191. QATAR CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 237. CANINE ATOPIC DERMATITIS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 238. CANINE ATOPIC DERMATITIS MARKET, FPNV POSITIONING MATRIX, 2023

The Canine Atopic Dermatitis Market was valued at USD 1.57 billion in 2023, expected to reach USD 1.69 billion in 2024, and is projected to grow at a CAGR of 8.40%, to USD 2.76 billion by 2030.

Canine Atopic Dermatitis (CAD) is a prevalent allergic condition in dogs characterized by inflammation of the skin due to allergens. The necessity for effective CAD treatment is underscored by the growing pet ownership and heightened awareness about pet health, which pushes demand for innovative therapies. The application of CAD treatments spans from veterinary clinics offering specialized dermatological services to home-care products incorporating antihistamines and immunosuppressant formulations. The end-use scope primarily involves pet owners and veterinary professionals seeking enhanced treatment options to improve pet welfare and alleviate symptoms. Market growth is significantly driven by the advancement of biotech and pharmaceutical products, increased R&D investments, and new product launches that offer more effective, targeted therapies with fewer side effects. Additionally, the rising prevalence of pet allergies and the humanization of pets-where pet owners increasingly treat pets as part of the family-create opportunities for premium-priced therapeutic solutions. However, limitations such as stringent regulatory approvals, potential side effects of long-term medication use, and the high cost of innovative treatments present challenges. Additional hurdles include the variability in pet response to treatment and a need for greater understanding of CAD's genetic and environmental triggers. Key potential opportunities in the market exist in developing novel biologics, personalized medicine approaches that tailor treatments to individual pet needs, and revolutionary diagnostic tools that enable early and accurate identification of CAD. Innovation areas focus on integrating data analytics and AI-driven platforms to predict allergy patterns and customize preventive measures. The market is dynamic, with a shift towards non-invasive treatments, nutraceuticals, and probiotic solutions, suggesting a future rich with potential as companies strive to address unmet consumer needs and expand the therapeutic arsenal against CAD. Balancing efficacy and affordability will be crucial for companies looking to capture growth and ensure broad adoption in a competitive landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Canine Atopic Dermatitis Market

The Canine Atopic Dermatitis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing number of pet ownership and rising pollution related to allergens on dogs
  • Rising focus on natural ingredients or non-pharmacological methods
• Market Restraints
  • Increasing use of off-label drugs among pets
• Market Opportunities
  • Rise in the R&D investments product launches for canine atopic dermatitis (CAD)
  • Ongoing demand for pet insurance and rising concerns among pet owners
• Market Challenges
  • Complex etiology of CAD & concerns over treatment efficacy and safety

Porter's Five Forces: A Strategic Tool for Navigating the Canine Atopic Dermatitis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Canine Atopic Dermatitis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Canine Atopic Dermatitis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Canine Atopic Dermatitis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Canine Atopic Dermatitis Market

A detailed market share analysis in the Canine Atopic Dermatitis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Canine Atopic Dermatitis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Canine Atopic Dermatitis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Canine Atopic Dermatitis Market

A strategic analysis of the Canine Atopic Dermatitis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Canine Atopic Dermatitis Market, highlighting leading vendors and their innovative profiles. These include AB Science SA, AbbVie, Inc., Agrolabo SpA, Bimeda, Inc., Bioceltix JSC, Bioiberica S.A.U., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Deep Marine Collagen, Elanco Animal Health Incorporated, Farnam Companies, Inc., IDEXX Laboratories, Inc., Incyte Corporation, Kemin Industries, Inc., LEO Pharma A/S, Merck & Co. Inc., Natural Dog Company, Nextmune, Nippon Zenyaku Kogyo Co., Ltd., Novartis AG, Ourofino Animal Health, Pfizer Inc, Phibro Animal Health Corporation, Regeneron Pharmaceuticals, Inc, Saiba Animal Health AG, Toray Industries Inc., Vetoquinol S.A., Virbac Corporation, Zinpro Corporation, Zoetis Inc., and Zymox by Pet King Brands LLC.

Market Segmentation & Coverage

This research report categorizes the Canine Atopic Dermatitis Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Antihistamines, Glucocorticoids, Immunosuppressants, and Monoclonal Antibodies.
• Based on Allergen, market is studied across Dander, Microorganisms, Mites, and Pollen.
• Based on Route of Administration, market is studied across Injectable, Oral, and Topical.
• Based on Distribution Channel, market is studied across Hospitals & Clinics, Online, and Retail Veterinary.
• Based on End-User, market is studied across Hospitals and Veternary Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing number of pet ownership and rising pollution related to allergens on dogs
    • 5.1.1.2. Rising focus on natural ingredients or non-pharmacological methods
  • 5.1.2. Restraints
    • 5.1.2.1. Increasing use of off-label drugs among pets
  • 5.1.3. Opportunities
    • 5.1.3.1. Rise in the R&D investments product launches for canine atopic dermatitis (CAD)
    • 5.1.3.2. Ongoing demand for pet insurance and rising concerns among pet owners
  • 5.1.4. Challenges
    • 5.1.4.1. Complex etiology of CAD & concerns over treatment efficacy and safety
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Expanding use of antihistamines and glucocorticoids for effective treatment of CAD
  • 5.2.2. Allergen: Dust mites and microscopic parasites prevail as the major cause of CAD
  • 5.2.3. Route of Administration: Injectables and orals to be the most preferred mode of medication application
  • 5.2.4. Distribution Channel: Emerging availability of CAD medications through online distribution channels
  • 5.2.5. End-User: Increasing CAD diagnosis in clinics and need for effective treatments
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Canine Atopic Dermatitis Market, by Product

• 6.1. Introduction
• 6.2. Antihistamines
• 6.3. Glucocorticoids
• 6.4. Immunosuppressants
• 6.5. Monoclonal Antibodies

7. Canine Atopic Dermatitis Market, by Allergen

• 7.1. Introduction
• 7.2. Dander
• 7.3. Microorganisms
• 7.4. Mites
• 7.5. Pollen

8. Canine Atopic Dermatitis Market, by Route of Administration

• 8.1. Introduction
• 8.2. Injectable
• 8.3. Oral
• 8.4. Topical

9. Canine Atopic Dermatitis Market, by Distribution Channel

• 9.1. Introduction
• 9.2. Hospitals & Clinics
• 9.3. Online
• 9.4. Retail Veterinary

10. Canine Atopic Dermatitis Market, by End-User

• 10.1. Introduction
• 10.2. Hospitals
• 10.3. Veternary Clinics

11. Americas Canine Atopic Dermatitis Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Canine Atopic Dermatitis Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Canine Atopic Dermatitis Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Zoetis Opens New State-of-the-Art Facility in Lincoln, NE, USA
  • 14.3.2. Zoetis Announces FDA Approval of Apoquel Chewable (oclacitinib chewable tablet) for Control of Pruritus Associated With Allergic Dermatitis and Control of Atopic Dermatitis in Dogs
  • 14.3.3. ILC Therapeutics entered into a strategic R&D partnership with Dechra Pharmaceuticals
  • 14.3.4. Bioiberica Launches Dog And Cat Collar For Atopic Dermatitis Featuring Company's Lipids-Based Biosfeen Ingredient
  • 14.3.5. Royal Canin North America Announces Launch of SKINTOPIC to Help in the Management of Canine Atopic Dermatitis
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AB Science SA
• 2. AbbVie, Inc.
• 3. Agrolabo SpA
• 4. Bimeda, Inc.
• 5. Bioceltix JSC
• 6. Bioiberica S.A.U.
• 7. Boehringer Ingelheim International GmbH
• 8. Ceva Sante Animale
• 9. Dechra Pharmaceuticals PLC
• 10. Deep Marine Collagen
• 11. Elanco Animal Health Incorporated
• 12. Farnam Companies, Inc.
• 13. IDEXX Laboratories, Inc.
• 14. Incyte Corporation
• 15. Kemin Industries, Inc.
• 16. LEO Pharma A/S
• 17. Merck & Co. Inc.
• 18. Natural Dog Company
• 19. Nextmune
• 20. Nippon Zenyaku Kogyo Co., Ltd.
• 21. Novartis AG
• 22. Ourofino Animal Health
• 23. Pfizer Inc
• 24. Phibro Animal Health Corporation
• 25. Regeneron Pharmaceuticals, Inc
• 26. Saiba Animal Health AG
• 27. Toray Industries Inc.
• 28. Vetoquinol S.A.
• 29. Virbac Corporation
• 30. Zinpro Corporation
• 31. Zoetis Inc.
• 32. Zymox by Pet King Brands LLC